The difference is I think the company will succeed and don't spend my time bashing it.
In fact I give the odds of MAA approval more than 75% or even 83%.
It won't be "a miracle" when Anavex succeeds. It will be the result of long developmental process that Anavex has been pursuing with focus. The process has had its setbacks as most long projects do and Anavex has gotten past those and is now on the cusp of approval.
People seem to forget that ANY approval of 2-73 represents a validation of the Anavex approach to disease treatment. It will be a paradigm shift in CNS disease treatment and quite possibly many other diseases. The prophylactic case has been made in murine models. That needs to be shown in humans but if it is, OMG.
Market Data 
Markets 
AI
